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Abstract
Background: Decreased fetal movements (DFM) are associated with fetal growth restriction and stillbirth, presumably linked
through an underlying placental dysfunction. Yet, the role of placental pathology has received limited attention in DFM
studies. Our main objective was to explore whether maternal perceptions of DFM were associated with placental pathology
in pregnancies recruited from a low-risk total population.
Methods/Principal Findings: Placentas from 129 DFM and 191 non-DFM pregnancies were examined according to
standardized macro- and microscopic protocols. DFM was defined as any maternal complaint of DFM leading to a hospital
examination. Morphological findings were timed and graded according to their estimated onset and clinical importance,
and classified in line with a newly constructed Norwegian classification system for reporting placental pathology. With our
population-based approach we were unable to link DFM to an overall measure of all forms of placental pathology (OR 1.3,
95% CI 0.8–2.2, p=0.249). However, placental pathology leading to imminent delivery could be a competing risk for DFM,
making separate subgroup analyses more appropriate. Our study suggests a link between DFM and macroscopic placental
pathology related to maternal, uteroplacental vessels, i.e. infarctions, placental lesions (intraplacental hematomas) and
abruptions. Although not statistically significant separately, a compound measure showed a significant association with
DFM (OR 2.4, 95%CI 1.1–5.0, p=0.023). This association was strengthened when we accounted for relevant temporal
aspects. More subtle microscopic materno-placental ischemic changes outside the areas of localized pathology showed no
association with DFM (OR 0.5, 95%CI 0.2–1.4, p=0.203). There was a strong association between placental pathology and
neonatal complications (OR 2.9, 95% CI 1.6–5.1, p,0.001).
Conclusions: In our population-based study we were generally unable to link maternally perceived DFM to placental
pathology. Some associations were seen for subgroups.
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Introduction
Fetal growth restriction (FGR) is associated with significant risk
for severe disabilities and death [1–3]. Risk can be reduced by
appropriate assessment, but the ability to detect FGR in antenatal
care remains weak [4]. The mother’s perception of fetal movement
(FM) is still the simplest source of information about the baby’s
well-being and should not be underrated. A maternal perception
of decreased fetal movement (DFM) is widely reported to be
associated with FGR [5–11]. DFM is also reported the days
preceding an unexplained stillbirth [5,12–14], suggesting that
interventions could have prevented morbidity and mortality
[15,16]. The majority of women examined for perceived DFM
in third trimester, however, continues with uncomplicated
pregnancies [17]. So even if a maternal perception of DFM is
rightly recognized as a good indicator of fetal compromise, its
predictive value is low.
The well-documented association between DFM, FGR and
stillbirth [1–4] is presumably linked to an underlying placental
dysfunction [18]. Pathological processes in the placenta may lead
to fetal hypoxia [19], either following profound acute circulatory
insults such as abruptions and hemorrhages, or longstanding
processes resulting in prolonged chronic hypoxia. When exposed
to nutrient and oxygen restriction, it is hypothesized that the fetus
will redistribute blood to vital organs [20] and will reduce non-
vital activities such as gross fetal movements, [21–23]. Studies have
reported that growth restricted fetuses have reduced fetal
movement compared to controls [24] and that they demonstrate
an almost dose-dependent reduction in FM during hypoxia
[23,25–27]. DFM has been found to be associated with abnormal
placental morphology paralleling those seen in placentas in FGR
pregnancies [18]. Although it is generally assumed and clinically
plausible that DFM reflects fetal adjustment to a negative energy
balance induced by reduced placental function, evidence to
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39259support this is limited. The first study on placental morphology
was published just recently and reported altered placental
structure and function with DFM [28,29].
A perception of DFM often causes anxiety [30,31] and results in
frequent unscheduled third trimester antenatal visits [5,8,9,16]. So
far, however, placental pathology in DFM studies have been
inadequately pursued [18]. A prospective FM counting study with
a subsequent blinded study of the placenta was initiated to reveal
information that may help to identify the DFM pregnancies at
greatest risk.
The placenta substudy forms the basis for this report. Our main
objective was to explore whether maternal perceptions of DFM
were associated with placental pathology in pregnancies recruited
from a low-risk total population. We hypothesized that DFM
placentas would show morphological changes consistent with
reduced placental function.
Methods
Ethics Statement
Written informed consent was obtained from all participants,
both for the FM counting study and the morphological
examination of the placenta following delivery. The study was
approved by the Regional Committee for Medical Research
Ethics, S-08694d, 2008/18353, 06.26.2009. There were no
minors or legally incompetent participants in the study.
The FM Counting Study
The placenta study is a case-cohort nested within a broader
prospective FM counting study initiated to explore FM counting
patterns and their relation to adverse pregnancy outcome. Thus all
pregnancies included in this placenta study were selected among
women who were already included in the population-based FM
counting study.
From July 2009 to July 2011, all women with singleton
pregnancies attending Østfold Hospital Trust for routine ultra-
sound screening in pregnancy week 17–19 were invited to the
study. After written informed consent, a total of 2468 women were
enrolled in the FM counting study, representing 42% of the
eligible population. Among them, 1445 (59%) later submitted their
FM chart and thus form the study group. Compared to the total
population of pregnant women at Østfold Hospital Trust (data
from Medical Birth Registry of Norway, year 2009 used as a
reference [32]), the study group included more primiparous
women (RR 1.2, 95%CI 1.2–1.3, p,0.001), fewer smoking
mothers (RR 0.5, 95%CI 0.4–0.5, p,0.001), fewer cesarean
sections (RR 0.8, 95%CI 0.7–0.8, p,0.001), fewer preterm (RR
0.8, 95%CI 0.6–0.9, p=0.028), and low birth weight babies (RR
0.6, 95%CI 0.4–0.9, p=0.006) (data not shown).
Participating women systematically recorded FM daily with a
modified ‘‘count-to-ten’’ approach, i.e. the time needed to perceive
ten movements. The counting protocol was according to
guidelines from the international collaboration Fetal Movement
Intervention Assessment (FEMINA) [5,8,9,33]. The information
provided to women about DFM and when to seek medical
attention is presented in full in Textbox S1 (Other 1). Women
were not provided with any fixed limits for DFM, but advised to
report significant and sustained decreases in the baby’s normal
activity. In the current report DFM is defined as any maternal
concern leading to a hospital examination.
The Placenta Substudy
From this prospective FM counting cohort there were two
different criteria for eligibility to the placenta study: (i) if the
mother had been examined in hospital care for a concern for
DFM after 24
0pregnancy week, or (ii) if the mother was among
pregnancies preselected to the placenta study at time of enrollment
in the FM counting study, independent of pregnancy outcome (a
population-based sample as controls). Some of the women
preselected to the population sample also experienced DFM and
were included as DFM pregnancies in the analyses, Figure 1. Only
babies without malformations were included in the analyses.
Since the placenta study was complementary to the FM
counting study, a preceding power calculation for a case-control
design was not performed. However, with our placenta sample a
power calculation shows that we would have been able to detect an
odds ratio for placental pathology of 2.0 in DFM compared to
non-DFM pregnancies.
Placental Examination
Information on gestational age, birth weight, and Apgar scores
was available for pathologists at time of examination. All placentas
were examined macroscopically by four designated pathologists
according to a standardized protocol. All DFM placentas and a
selection of non-DFM placentas were examined microscopically
by a single, experienced pathologist with special interest in
placental pathology (BR). The non-DFM placentas as controls
were selected independently from their birth outcome. For every
two DFM placentas we selected three non-DFM placentas (case-
control ratio1:1.5). The pathologist performing the microscopic
examinations was blinded for macroscopic findings and DFM
information.
Placentas were weighed (without cord and membranes),
measured and inspected for focal lesions. Focal lesions were
reported as estimated % of total placental volume, location central
or peripheral and arbitrarily timed as acute (hemorrhagic changes)
(,48 hours), subacute (hemorrhagic and fibrous changes) (2–20
days), or longstanding (fibrous changes) (.=21 days). The gross
macroscopic pathology was graded according to assumed clinical
impact as:
(1) no pathology: placentas without abnormalities
(2) minor impact: abnormalities in placental shape, bilobate
placenta, circumvallate placenta without bleeding, meconium
stained membranes, peripheral infarctions (,10%)
(3) potential impact: velamentous or marginal cord insertion,
true knots
(4) moderate impact: infarctions (central infarctions 5–9% or
peripheral infarctions $10%)
(5) significant impact: focal lesions like central infarctions and
hemorrhages $10%, abruptions.
Standard tissue sections were taken from (i) membranes and
umbilical cord, (ii) cord insertion site and placental near cord, (iii)
full thickness macroscopically normal placenta, and (iv) two
sections from the maternal plate. Additional sections were taken
from centrally located focal parenchymal lesions. The sections
were routinely formalin fixed, processed and embedded in
paraffin. For the microscopic review only sections stained with
Hematoxylin and Eosin (HE) were used.
Placental pathology from the microscopic examinations was
categorized into nine groups according to a new Norwegian
classification scheme [34], Table 1. The assumed clinical impact of
the various processes was graded similarly to the macroscopic
examination: (0) no pathology, (1) minor-, (2) potential- (3)
moderate- and (4) significant impact, and timed accordingly.
Only pathologies with clinical impact grade 3 and 4 are included
as pathology in the analyses. Separate analyses are presented for
Decreased Fetal Movement and Placental Pathology
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Analyses are based on the last DFM consultation if several.
Linking placental pathology present at term to early third
trimester DFM consultations may be dubious. To get a more valid
estimate of the association between DFM and placental pathology,
we performed two separate subanalyses. First, we delimited the
subset to DFM consultations occurring within the last seven days
before birth and compared placental pathology between DFM and
non-DFM pregnancies. With this approach the placental pathol-
ogy would most likely precede the DFM consultation in time.
Second, we delimited the subset to DFM consultations occurring
within the last 21 days before birth and included only acute and
subacute placental pathology, i.e. with estimated onset within the
last 21 days, and compared these pathologies between DFM and
non-DFM pregnancies. We were then able to assess whether DFM
and placental pathology likely coincided in time.
Demographic indicators and information on birth outcome
were collected from antenatal pregnancy charts and hospital
records. Birth weight was adjusted for gestational age and sex.
Baby weight below the 10
th percentile was classified as small for
gestational age (SGA) [35,36]. We have defined neonatal
complications as preterm birth, SGA, infections, Apgar scores
,75min, or transfer to neonatal care unit for conditions relevant to
fetal growth restriction or fetal distress, including respiratory
syndrome and cerebral irritation. Classifications comply with
definitions from Medical Birth Registry of Norway [32]. Respi-
ratory distress is defined as typical signs or X ray findings, and
cerebral irritation is defined as unrest, trembling, stiffness, and
other signs of cerebral excitation [32].
Statistical Analyses
We used SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). To
compare the likelihood of events between groups, we calculated
Figure 1. Flowchart for data collection.
doi:10.1371/journal.pone.0039259.g001
Table 1. A systematic and standardized classification of
placental pathology [34].
Category Diagnostic categories
1 Normal placenta
2 Placenta with chorioamnionitis
3 Placenta with villitis (usually VUE)
4 Placenta with materno-placental circulatory disorder
5 Placenta with feto-placental circulatory disorder
6 Placenta with maturation disturbance
7 Placenta with findings suggestive of gene aberration
8 Placenta with placentation defect
9 Placenta with other pathology
doi:10.1371/journal.pone.0039259.t001
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risks (RR) when appropriate. Two samples t test was used to
explore relationships between continuous variables. The level of
statistical significance was set at p,0.05.
Results
The final sample of 320 placentas with complete macroscopic
and microscopic examinations consisted of 129 DFM and 191
non-DFM placentas. All babies included in the analyses were live
born. For data collection, see flow chart Figure 1. There were no
statistically significant differences in maternal characteristics
between DFM and non-DFM pregnancies, Table 2.
Generally, we were unable to link DFM to an overall measure of
all forms of placental pathology with statistical significance (OR
1.3, 95% CI 0.8–2.2, p=0.249), Table 3. However, DFM seems
more closely associated with macroscopic placental pathology
related to maternal, uteroplacental vessels, i.e. infarctions,
placental lesions (intraplacental hematomas) and abruptions. All
odds ratios for these subcategories were higher than unity,
although not statistically significant separately. Yet, when these
subcategories were merged, the compound measure showed a
significant association with DFM (OR 2.4, 95%CI 1.1–5.0,
p=0.023), Table 3. This association was strengthened when we
restricted the analysis to DFM consultations within the last seven
days before birth (OR 3.0, 95%CI 1.1–7.6, p=0.025). The same
applied to the subsample with DFM consultations and estimated
onset of placental pathology within the last 21 days preceding birth
(OR 3.5. 95%CI 1.1–11.3, p=0.038).
There was no association with DFM for more subtle micro-
scopic materno-placental ischemic changes outside the areas of
localized pathology (OR 0.5, 95%CI 0.2–1.4, p=0.203), Table 3.
In cases of acute chorioamnionitis we found no association, as the
DFM consultations preceded the pathology onset by large margins
and thus were unrelated. Placentas from DFM and non-DFM
pregnancies were similar in mean trimmed weight and mean fetal
placental weight ratio across samples. A quintile distribution of
placental weight showed no differences between DFM and non-
DFM pregnancies. Fetal vessels in the membranes are vulnerable
to injury and thrombosis, and are more susceptible to compression
by fetal parts resulting in obstruction of blood flow. We found cord
anomalies, including true knots and velamentous and marginal
cord insertions, to be similar between the groups, Table 3. Since
abnormal cord insertion site has been linked to SGA [37] as well
as DFM [29], we restricted the analysis to include only
velamentous and marginal cord insertions. However, results were
the same (data not shown).
Table 2. Maternal and fetal characteristics and birth outcome for DFM versus non-DFM pregnancies, from pregnancy week 24
0
(n=320).
DFM pregnancies,
n=129
Non-DFM
pregnancies,
n =191
n (%) n (%) OR (95% CI) p
"
MATERNAL CHARACTERISTICS
Maternal age $35 yrs 19 (14.7) 34 (17.8) 0.8 (0.4–1.5) 0.469
Primiparous 79 (61.2) 108 (56.5) 1.2 (0.8–1.9) 0.403
Maternal obesity (Body Mass Index $30 kg/m
2) 16 (12.4) 34 (17.8) 0.7 (0.3–1.2) 0.185
Maternal smoking in pregnancy 11 (8.5) 17 (8.9) 1.0 (0.4–2.1) 0.924
Pre-pregnancy maternal health or obstetric risk factors
a 17 (13.2) 14 (7.3) 1.9 (0.9–4.1) 0.087
DELIVERY ONSET
Spontaneous 91 (70.5) 143 (74.9) 0.8 (0.5–1.3) 0.392
Induced 28 (21.7) 40 (20.9) 1.0 (0.6–1.8) 0.581
Elective cesarean section 6 (4.7) 7 (3.7) 1.3 (0.4–3.9) 0.843
Emergency cesarean section (ECS) prior to contractions 4 (3.1) 1 (0,5) 6.1 (0.7–55.0) 0.108
DELIVERY COMPLICATIONS
Intrapartum ECS on non-reassuring fetal state
b 5 (3.9) 12 (6.3) 0.6 (0.2–1.8) 0.351
FETAL CHARACTERISTICS AND BIRTH OUTCOME
Gestational age in weeks at birth, mean [range] 39
6 [30
6–42
5]3 9
6 [30
3–42
4] - 0.997
Birth weight in grams, mean [SD] 3568 (593) 3555 (506) - 0.831
Neonatal complications
l 26 (20.2) 37 (19.4) 1.1 (0.6–1.8) 0.863
Small for gestational age ,10
th centile
ll 14 (10.9) 21 (11.0) 1.0 (0.5–2.0) 0.968
Preterm birth (week 24
0–36
6) 8 (6.2) 7 (3.7) 1.7 (0.6–4.9) 0.298
"p-values refer to odds ratios for categorical data and t-test for continuous variables for comparisons between DFM vs non-DFM pregnancies.
aMaternal general health risk factors include: diabetes type I and II, chronic renal, hypertensive or coronary disease, inflammatory and collagen disease, epilepsy or
coagulopathy. Obstetric risk factors include: previous pregnancy with FGR, stillbirth.21 weeks, fetal malformations, serious pre eclampsia, preterm delivery or
spontaneous abortions .3.
bNon-reassuring fetal state: pathological CTG or Doppler or other signs of fetal distress.
lNeonatal complications: preterm birth, SGA, infections, Apgar scores ,75min or transfer to NCU for conditions relevant to fetal growth restriction or fetal distress
(respiratory syndrome or cerebral irritation).
llSmall for gestational age (SGA): birth weight for gestational age below 10
th percentile adjusted for maternal height and pre pregnancy weight and infant sex.
doi:10.1371/journal.pone.0039259.t002
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presented in Table 4 with information on gestational age at time of
DFM and days between DFM and birth. We found no association
between having recurrent DFM consultations and overall placen-
tal pathology (OR 1.5, 95% CI 0.4–5.8, p=0.525) or between
having recurrent DFM consultations and neonatal complications
(OR 1.9, 95% CI 0.8–4.6, p=0.167). For DFM infants later
diagnosed as SGA, the median time between diagnosis of
intrauterine growth restriction (fetal weight estimate ,–10% by
ultrasound measurement) and delivery was 20 days, range 2–63.
On birth outcome a strong association between placental
pathology and neonatal complications was found, Table 5. The
strongest associations with birth outcome were seen for placental
pathology in category four according to the Norwegian classifica-
tion system, i.e. materno-placental circulatory disorders. This
category relates to maternal vascular pathology. It includes both
longstanding, chronic placental processes such as old infarctions
and diffuse ischemic changes, and acute episodes that have
occurred closer to birth like abruptions. These associations were
present both for the more abrupt circulatory insults and the subtle
ischemic changes.
Neither placental ascending infections (placental pathology
category two) nor cord anomalies were associated with the birth
outcomes, Table 5. The remaining categories were small, which
limited subgroup analyses.
We found no statistically significant differences in birth outcome
between DFM and non-DFM pregnancies, Table 2.
Representativeness of Sample
Placentas from approximately two thirds of the DFM pregnan-
cies were eventually included: 85% from DFM pregnancies that
were among pregnancies initially preselected to the population
sample and 46% from DFM pregnancies outside the population
sample, Figure 1. In 78 (38%) of the DFM pregnancies the
placenta was lost to the study. A sensitivity analysis showed that
DFM pregnancies with (n=129) or without (n=78) the placenta
included were similar in terms of mean infant birth weight (3555
grams (SD 609) versus 3634 grams (SD 523), p=0.350) and mean
gestational age at birth (40
0 weeks (SD 2) versus 40
3 weeks (SD
1.6), p=0.156). They were also similar in terms of neonatal
complications (OR 1.1, 95% CI 0.5–2.1, p=0.872), SGA (OR
0.9, 95% CI 0.4–2.3, p=0.854) and preterm infants (OR 1.2, 95%
CI 0.4–4.2, p=0.749).
Discussion
To our knowledge, this is the first population-based study that
compares placental morphology in DFM and non-DFM pregnan-
cies. We were unable to link DFM to placental pathology with
statistical significance, although our data suggest higher odds for a
subgroup of placental pathology in DFM-pregnancies, primarily
related to abrupt circulatory insults. The maternal ability to detect
SGA and neonatal complications was limited. With our popula-
tion-based approach we faced the well-known challenge of low
power when studying rare events in prospective cohort designs.
However, the placenta study is part of a broader FM counting
study where this design was most suitable.
Generally, placental pathology contributed little to explain third
trimester maternally perceived DFM. Two factors need to be
mentioned. First, some forms of placental pathology are known to
trigger imminent delivery, among them acute chorioamnionitis,
and may serve as competing risk for DFM. An overall measure of
placental pathology could therefore be misleading, since placental
pathology relevant for DFM may be underestimated. So subgroup
analyses may be more appropriate. Second, linking placental
pathology present at term to early third trimester DFM
consultations may be dubious. Placental pathology must precede
the DFM consultation in time to be relevant for DFM. By
necessity, a retrospective estimate of pathology onset is broad,
especially for pathology with estimated onset .21 days prior to
birth.
To get a more valid estimate of the associations between DFM
and placental pathology, we therefore restricted the analyses to
include only DFM consultations occurring within the last seven
days before birth. The result from this subgroup analysis
confirmed and even strengthened the result from the total sample;
DFM seemed more associated with abrupt, major circulatory
insults resulting from obstruction of maternal uteroplacental
vessels. Discrepancies between the two analyses were primarily
linked to cases of acute chorioamnionitis, which were unrelated in
time with the DFM consultation, similar to what was seen for the
more diffuse ischemic changes.
The same result emerged when we restricted the analysis to
include DFM pregnancies occurring within the last 21 days before
birth and compared only placental pathology with acute or
subacute onset (,21 days) between DFM and non-DFM
pregnancies, implying that events were more likely to have
coincided in time. Again the associations between DFM and
macroscopic maternal vascular pathology were strengthened.
Thus associations between DFM and more abrupt circulatory
events remained also when temporal associations were accounted
for. The clinical implications are, however, not clear. Important
macroscopic indicators of placental function, such as placental
trimmed weight and fetal placental weight ratio, were not different
between DFM and non-DFM pregnancies in our study, indicating
overall healthy placentas with substantial reserve capacity in both
groups. Placental weight has previously been found to be
predictive of maternal disease, obstetric outcome and perinatal
morbidity and mortality [38].
There are few studies to support or refute our findings, as
research linking placental dysfunction to DFM is scarce. The first
study actually investigating placenta morphology in DFM
pregnancies was presented just recently [28,29]. In comparing
placentas from 36 DFM pregnancies with 36 healthy controls,
Table 4. Characteristics of consultations for DFM from 129 pregnancies.
CHARACTERISTICS OF DFM CONSULTATIONS
First DFM consultation,
n=129
Second DFM
consultation, n=10
Third DFM consultation,
n=2
Median [range] Median [range] Median [range]
Gestational age in weeks at time of DFM consultation 37.3 [24.1–41.5] 37.7 [31.6–40.7] 38.6 [36.7–40.6]
Days between DFM consultation and delivery 14 [0–122] 13 [1–46] 3.5 [2–5]
doi:10.1371/journal.pone.0039259.t004
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cies were smaller (lighter, with smaller surface area), had more
macroscopic infarctions, and were more likely to have abnormal
shape and eccentric cord insertion than those from healthy
pregnancies. Microscopic examination revealed ischemic changes
indicating maternal vascular pathology with increased number of
syncytial knots, fewer blood vessels, and reduced area of
trophoblast per villus [28,29].
While these results apparently differ from our findings, direct
comparison may be deceiving. The previous study included only
pregnancies where perceived DFM lasted more than 12 hours and
where the baby was delivered within seven days of presentation,
representing 12% of the DFM consultations in the study (36/305).
These selected high-risk DFM pregnancies were compared with
selected healthy controls, i.e. sick versus healthy. In our
population-based approach, we compared women with and
without a maternal complaint for DFM without further selection,
a measure known to have low predictive value, but important in
clinical practice. These differences in design are clearly reflected in
the study samples. Their DFM sample included a substantial
number of smaller placentas with lower fetal placental weight
ratio, whereas DFM and non-DFM placentas in our population-
based sample were comparable in size. The differences in
placental ischemic changes in the two studies may mainly reflect
the differences in the study cohorts, partially also differences in
criteria and classification. The pathology examination procedure
differed between the studies. Again our study has a focus on every-
day approaches. We have thus used standard, routine examination
protocols, both in the macroscopic and microscopic examinations,
assessing HE sections only.
While acknowledging that differences in our study were
expected to be smaller, our design deliberately aimed at being
relevant for the everyday situations facing obstetricians and
midwives. With the similarities in aims between our and the
previous study, we have purposely amended our analysis where
appropriate to facilitate comparison. The studies are thus
complementary and each provides building blocks to fill in the
knowledge gaps.
The association between placental pathology and FGR and
stillbirth has previously been documented [39–41]. Consistent
with these studies we found strong associations between SGA and
placental pathology, both for the non-macroscopic, microscopi-
cally identified ischemic changes and for the macroscopically more
abrupt, circulatory insults. However, we only found an association
with DFM for the latter category. Birth outcomes appear similar
between DFM and non-DFM pregnancies. This is in line with the
overall result of minor differences in placental pathology between
DFM and non-DFM placentas in our study. In addition, the effect
of focal obstruction of maternal uteroplacental vessels is potentially
less severe in normally sized placentas, as in our sample, with
capacity for compensatory mechanisms. Thus major differences in
birth outcome should not be expected.
Other factors may also have improved birth outcomes for DFM
pregnancies. The effect of being included in a study often
Table 5. Placental pathology by birth outcome (n=320).
Characteristics
Placental
pathology
No placental
pathology
n (%) n (%) OR (95% CI) P
"
PLACENTA CHARACTERISTICS
Trimmed placental weight in grams, mean [range] 546 [274–1000] 594 [286–1010] - 0.011
BIRTH OUTCOME
PLACENTAL PATHOLOGY, TOTAL
a
Neonatal complications
l 29/88 (33.0) 34/232 (14.7) 2.9 (1.6–5.1) ,0.001
Small for gestational age ,10
th centile
ll 19/88 (21.6) 16/232 (6.9) 3.7 (1.8–7.6) ,0.001
Preterm birth (week 24
0–36
6) 4/88 (4.5) 11/232 (4.7) 1.0 (0.3–3.1) 0.941
MATERNO-PLACENTAL CIRCULATORY DISORDERS, abrupt circulatory insults
Neonatal complications 10/32 (31.3) 53/288(18.4) 2.0 (0.9–4.5) 0.088
Small for gestational age ,10
th centile 9/32 (28.1) 26/288(9.0) 3.9 (1.6–9.4) 0.002
Preterm birth (week 24
0–36
6) 2/32 (6.3) 13/288 (4.5) 1.4 (0.3–6.6) 0.661
MATERNO-PLACENTAL CIRCULATORY DISORDERS, ischemic changes
Neonatal complications 11/22 (50.0) 52/298 (17.4) 4.0 (1.9–11.5) 0.001
Small for gestational age ,10
th centile 7/22 (31.8) 28/298 (9.4) 4.5 (1.7–12.0) 0.003
Preterm birth (week 24
0–36
6) 2/22 (9.1) 13/298 (4.4) 2.2 (0.5–10.4) 0.323
CORD ANOMALIES WITH POTENTIAL IMPACT
1
Neonatal complications 4/20 (20.0) 59/300 (19.7) 1.0 (0.3–3.2) 0.971
Small for gestational age ,10
th centile 3/20 (15.0) 32/300 (10.7) 1.5 (0.4–5.3) 0.550
Preterm birth (week 24
0–36
6) 1/20 (5.0) 14/300 (4.7) 1.1 (0.1–8.6) 0.946
"p-values refer to odds ratio for categorical data and t-test for continuous variables for comparisons between pregnancies with or without placental pathology.
aIncludes all cases with pathology with assumed moderate to important clinical impact from macroscopic or microscopic examination.
lNeonatal complications: preterm birth, SGA, infections, Apgar scores ,75min or transfer to NCU for conditions relevant to fetal growth restriction or fetal distress
(respiratory syndrome or cerebral irritation).
iiSmall for gestational age: birth weight for gestational below 10
th percentile adjusted for maternal height and pre pregnancy weight and infant sex.
1Includes the cord anomalies; true umbilical cord knots (n=7), velamentous (n=5) and marginal cord (n=9) insertion.
doi:10.1371/journal.pone.0039259.t005
Decreased Fetal Movement and Placental Pathology
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39259influences participant behavior, usually in a beneficial direction
[42], i.e. maternal care seeking behavior. Improved clinical care
such as appropriate management, timing of delivery and delivery
interventions may be more likely in DFM pregnancies. Our study
was, however, neither designed for nor powered to measure such
effects of maternal monitoring of FM on birth outcome.
The strong association between placental pathology and
neonatal complications may have been reinforced as pathologists
were informed about gestational age, birth weight and Apgar
scores. This information is, however, vital in placental examina-
tion since placenta is a dynamic organ, constantly developing and
maturing throughout pregnancy. In terms of DFM, a number of
macro examinations were conducted during parts of the study
period when DFM placentas were the only placentas collected,
implying that pathologists were inevitably aware of DFM status
during part of the study period. The strict protocol for
macroscopic registration and standardized sectioning makes this
awareness less prone to bias. Importantly, when micro examina-
tions were conducted, the pathologist was unaware of DFM status.
The well defined microscopic criteria of the newly constructed
Norwegian classification scheme were strictly applied.
Consistent with earlier studies [33,43,44], we found that the
predictive value of maternally perceived FM for identification of
SGA and neonatal complications was low. Women’s perception of
FM is known to be affected by pathological and non-pathological
entities [44]. A valuable contribution from the previous study was
that it managed to link DFM to placental pathology [29].
However, this was based on a highly selected risk group of DFM
pregnancies representing less than one percent of its obstetric
source population. With our population-based approach we were
unable to replicate these results, illustrating how difficult it can be
to interpret DFM both for the mothers and health care
professionals. Since women will continue to report concerns for
DFM [5,8,9,16], simple tools to help mothers maintain a safe
pregnancy is needed.
In a recent Lancet series on stillbirth prevention, screening for
placental insufficiency and better management of DFM pregnan-
cies were rated among top ten research priorities [15]. A natural
first step would be to improve women’s ability to recognize the
important changes in FM so as to ensure appropriate care-seeking
behavior. In the broader FM counting study, placenta data will be
included as an objective measure to explore whether FM counting
patterns contain information that can support maternal common
sense. Given appropriate care seeking behavior, the potential role
of placental biomarkers may provide a promising supplement to
identify those DFM pregnancies at highest risk of poor outcome.
Preliminary results from a DFM study have reported that DFM
pregnancies with poor birth outcome showed reduced plasma
concentrations of hCG and hPL compared to DFM pregnancies
with normal outcome [21,41]. Dysregulation of placental function
was suggested as a clue to the underlying pathology.
Conclusion
In our population-based study we were generally unable to link
maternally perceived DFM to underlying placental pathology,
although some associations were seen for subgroups. Maternal
ability to identify FGR was low. In order to enhance the role of
FM counting, further research must focus on ways to help women
to identify fetal compromise from chronic placental pathology.
Supporting Information
Textbox S1 Information about decreased fetal move-
ment (DFM) provided to the mothers.
(DOC)
Acknowledgments
This study is carried out in close collaboration between the Norwegian
Institute of Public Health, Østfold Hospital Trust Fredrikstad and Oslo
University Hospital Ulleva ˚l. We want to thank Lotte Gundersen, Reidun
Mollestad, Sigrunn Talberg and Anne Karin Henriksen at Department of
Pathology, Østfold Hospital Trust for their technical support and help and
the pathologists Elena Kostadinova Kotseva, at Østfold Hospital Trust and
Gitta Turowski at Oslo University Hospital Ulleval, for their help. We also
want to thank Tone Larsen, the coordinating midwife at Østfold Hospital
Trust for her strong efforts in study implementation and follow-up of
participants and Dr. Christopher Finne Riley for facilitating the study
within the hospital. We also acknowledge our colleagues, Jorid Eide and Eli
Saastad at the Norwegian Institute of Public Health for their support and
help. Finally, we thank all the participating mothers for their willingness to
contribute to this research.
Author Contributions
Conceived and designed the experiments: BAW BR JFF. Performed the
experiments: BAW BR NPK. Analyzed the data: BAW BR JFF.
Contributed reagents/materials/analysis tools: BR NPK. Wrote the paper:
BAW BR JFF.
References
1. Clausson B, Gardosi J, Francis A, Cnattingius S (2001) Perinatal outcome in
SGA births defined by customised versus population-based birthweight
standards. Br J Obstet Gynaecol 108: 830–4.
2. Frøen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B (2004)
Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet
Gynecol Scand 83: 801–7.
3. Gilbert WM, Danielsen B (2003) Pregnancy outcomes associated with
intrauterine growth restriction. Am J Obstet Gynecol 188: 1596–9.
4. Lindqvist PG, Molin J (2005) Does antenatal identification of small-for-
gestational age fetuses significantly improve their outcome? Ultrasound Obstet
Gynecol 25: 258–264.
5. Frøen JF, Saastad E, Tveit JV, Børdahl PE, Stray-Pedersen B (2005) [Clinical
practice variation in reduced fetal movements]. Tidsskr Nor Laegeforen 125:
2631–2634.
6. Heazell AE, Sumathi GM, Bhatti NR (2005) What investigation is appropriate
following maternal perception of reduced fetal movements? J Obstet Gynaecol
25: 648–650.
7. Sergent F, Lefevre A, Verspyck E, Marpeau L (2005) [Decreased fetal
movements in the third trimester: what to do?]. Gynecol Obstet Fertil 33:
861–869.
8. Tveit JVH, Saastad E, Stray-Pedersen B, Børdahl PE, Flenady V, et al. (2010)
Correction: Reduction of late stillbirth with the introduction of fetal movement
information and guidelines - a clinical quality improvement. BMC Pregnancy
and Childbirth 10: 49.
9. Tveit JV, Saastad E, Stray-Pedersen B, Bordahl PE, Flenady V, et al. (2009)
Reduction of late stillbirth with the introduction of fetal movement information
and guidelines - a clinical quality improvement. BMC Pregnancy Childbirth 9:
32. 1471-2393-9-32 [pii];10.1186/1471-2393-9-32 [doi].
10. Valentin L, Marsal K, Wahlgren L (1986) Subjective recording of fetal
movements. III. Screening of a pregnant population; the clinical significance of
decreased fetal movement counts. Acta Obstet Gynecol Scand 65: 753–8.
11. Whitty JE, Garfinkel DA, Divon MY (1991) Maternal perception of decreased
fetal movement as an indication for antepartum testing in a low-risk population.
Am J Obstet Gynecol 165: 1084–8.
12. Frøen JF, Arnestad M, Frey K, Vege A ˚, Saugstad OD, et al. (2001) Risk factors
for sudden intrauterine unexplained death: Epidemiologic characteristics of
singleton cases in Oslo, Norway, 1986–1995. Am J Obstet Gynecol 184: 694–
702.
13. Pearson JF, Weaver JB (1976) Fetal activity and fetal wellbeing: an evaluation.
Br Med J 1: 1305–7.
14. Sadovsky E, Yaffe H (1973) Daily fetal movement recording and fetal prognosis.
Obstet Gynecol 41: 845–50.
15. Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, et al. (2011) Stillbirths:
the way forward in high-income countries. Lancet 377: 1703–1717. S0140-
6736(11)60064-0 [pii];10.1016/S0140-6736(11)60064-0 [doi].
16. Frøen JF (2004) A kick from within - fetal movement counting and the cancelled
progress in antenatal care. J Perinat Med 32: 13–24.
Decreased Fetal Movement and Placental Pathology
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e3925917. Tveit JV, Saastad E, Stray-Pedersen B, Bordahl PE, Froen JF (2009) Maternal
characteristics and pregnancy outcomes in women presenting with decreased
fetal movements in late pregnancy. Acta Obstet Gynecol Scand 88: 1345–1351.
18. Warrander LK, Heazell AE (2011) Identifying placental dysfunction in women
with reduced fetal movements can be used to predict patients at increased risk of
pregnancy complications. Med Hypotheses 76: 17–20. S0306-9877(10)00324-5
[pii];10.1016/j.mehy.2010.08.020 [doi].
19. Bendon RW (2001) Review of some causes of stillbirth. Pediatric &
Developmental Pathology 4: 517–31.
20. Mari G, Deter RL (1992) Middle cerebral artery flow velocity waveforms in
normal and small-for-gestational-age fetuses. Am J Obstet Gynecol 166: 1262–
1270.
21. Bekedam DJ, Visser GH (1985) Effects of hypoxemic events on breathing, body
movements, and heart rate variation: a study in growth-retarded human fetuses.
Am J Obstet Gynecol 153: 52–56.
22. Bocking AD (2003) Assessment of fetal heart rate and fetal movements in
detecting oxygen deprivation in-utero. European Journal of Obstetrics,
Gynecology, & Reproductive Biology 110 Suppl 1: 108–12.
23. Ribbert LS, Nicolaides KH, Visser GH (1993) Prediction of fetal acidaemia in
intrauterine growth retardation: comparison of quantified fetal activity with
biophysical profile score. Br J Obstet Gynaecol 100: 653–656.
24. Bekedam DJ, Visser GH, de Vries JJ, Prechtl HF (1985) Motor behaviour in the
growth retarded fetus. Early Hum Dev 12: 155–165.
25. Sival DA, Visser GHA, Prechtl HFR (1992) The Effect of Intrauterine Growth-
Retardation on the Quality of General Movements in the Human Fetus. Early
Hum Dev 28: 119–132.
26. Vindla S, Sahota DS, Coppens M, James DK (1997) Computerized analysis of
behavior in fetuses with congenital abnormalities. Ultrasound Obstet Gynecol 9:
302–309.
27. Vindla S, James D, Sahota D (1999) Comparison of unstimulated and stimulated
behaviour in human fetuses with congenital abnormalities. Fetal Diagn Ther 14:
156–165.
28. Heazell AEP, Warrander LK, Greenwood SL, Jones RL, Sibley CP (2010)
Placental size is reduced and placental infarction and syncytial knots are
increased in pregnancies complicated by decreased fetal movement [Abstract].
Placenta: Abstracts for the forthcoming International Federation of Placenta
Associations Meeting 2010 31: A103.
29. Warrander LK, Batra G, Bernatavicius G, Greenwood SL, Dutton P, et al.
(2012) Maternal perception of reduced fetal movements is associated with altered
placental structure and function. PLoS ONE 7: e34851. 10.1371/journal.-
pone.0034851 [doi];PONE-D-11-22042 [pii].
30. Saastad E, Ahlborg T, Froen JF (2008) Low maternal awareness of fetal
movement is associated with small for gestational age infants. J Midwifery
Womens Health 53: 345–352.
31. Saastad E, Tveit JV, Flenady V, Stray-Pedersen B, Fretts R, et al. (2010)
Implementation of uniform information on fetal movement in a Norwegian
population reduces delayed reporting of decreased fetal movement and stillbirths
in primiparous women - a clinical quality improvement. BMC Res Notes 3: 2.
32. Norwegian Institute of Public Health (2011 December) Medical Birth Registry of
Norway. Available: http://mfr-nesstar.uib.no/mfr/.
33. Winje B, Saastad E, Gunnes N, Tveit J, Stray-Pedersen B, et al. (2011) Analysis
of ‘count-to-ten’ fetal movement charts: a prospective cohort study. Bjog 118:
1229–1238. 10.1111/j.1471-0528.2011.02993.x [doi].
34. Roald B, Turowski G, Collett K, Laurini R, Hanssen T, et al. (2010) A
systematic and standardized classification of placental pathology: A Norwegian
enterprise [Abstract]: Abstract P1.6. Proc. of the International Federation of
Placenta Associations. Placenta: Abstracts from the forthcoming International
Federation of Placenta Associations Meeting 2010 31: A20.
35. Eik-Nes SH, Grøttum P, Gjessing HK (2007) Available: http://www.nsfm.no/
esnurra/0.php.
36. Gjessing HK, Grottum P, Eik-Nes SH (2007) A direct method for ultrasound
prediction of day of delivery: a new, population-based approach. Ultrasound
Obstet Gynecol 30: 19–27. 10.1002/uog.4053 [doi].
37. Biswas S, Ghosh SK (2008) Gross morphological changes of placentas associated
with intrauterine growth restriction of fetuses: a case control study. Early Hum
Dev 84: 357–362. S0378-3782(07)00176-4 [pii];10.1016/j.earlhum-
dev.2007.09.017 [doi].
38. Almog B, Shehata F, Aljabri S, Levin I, Shalom-Paz E, et al. (2011) Placenta
weight percentile curves for singleton and twins deliveries. Placenta 32: 58–62.
S0143-4004(10)00386-3 [pii];10.1016/j.placenta.2010.10.008 [doi].
39. Kidron D, Bernheim J, Aviram R (2009) Placental findings contributing to fetal
death, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta 30:
700–704. S0143-4004(09)00175-1 [pii];10.1016/j.placenta.2009.05.009 [doi].
40. Redline RW (2008) Placental pathology: a systematic approach with clinical
correlations. Placenta 29 Suppl A: S86-S91. S0143-4004(07)00219-6
[pii];10.1016/j.placenta.2007.09.003 [doi].
41. Salafia CM (1997) Placental pathology of fetal growth restriction. Clin Obstet
Gynecol 40: 740–749.
42. John M Last, Editor (2008) A dictionary of epidemiology New York, New York:
Oxford University Press. 320 p.
43. Frøen JF, Heazell AE, Tveit JV, Saastad E, Fretts RC, et al. (2008) Fetal
movement assessment. Semin Perinatol 32: 243–246.
44. Heazell AE, Frøen JF (2008) Methods of fetal movement counting and the
detection of fetal compromise. J Obstet Gynaecol 28: 147–154.
Decreased Fetal Movement and Placental Pathology
PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e39259